11th International Conference on Malignant Lymphoma

In this review:

Hodgkin lymphoma

Aggressive lymphoma

Radiotherapy and early stage

Indolent lymphoma: R-CVP vs. R-CHOP vs. R-FM in advanced-stage FL initial treatment

PET: risk-adapted therapy in advanced stage DLBCL

CLL: PCI-32765 in poor-risk CLLT-cell lymphomas: brentuximab vedotin in relapsed/refractory
systemic ALCL

Download PDF Subscribe